Results 191 to 200 of about 43,118 (240)
Some of the next articles are maybe not open access.
Inhibitors of crayfish glutamic acid decarboxylase
Neurochemical Research, 1984Crayfish glutamic acid decarboxylase (GAD), like the homologous enzymes from other species, is inhibited by carbonyl-trapping agents (e.g. aminooxyacetic acid; AOAA) and sulfhydryl reagents (e.g. 5,5'-dithiobis-(2-nitrobenzoic acid); DTNB). It also is inhibited by the product GABA, many anions (e.g. SCN- and Cl-), and some cations (e.g. Zn+2).
R M, Grossfeld, S W, Yancey, C F, Baxter
openaire +2 more sources
Glutamic acid decarboxylase antibodies in Satoyoshi syndrome
Annals of Neurology, 2004Contains fulltext : 58378.pdf (Publisher’s version ) (Closed access)
Drost, G. +3 more
openaire +4 more sources
Circular dichroism of L-glutamic acid decarboxylase
Biochemical and Biophysical Research Communications, 1967Shukuya and Schwert (1960a) have shown that L-ylutamic acid decarboxylase (GAD) from E_. coli exhibits a sharply pHdependen,t reversible spectral change centered at pH 5.6. At pH's less than 5, the enzyme has an absorbance peak at 415 mp, while at pH's greater than 6, this peak is replaced by one at 340 mu.
T E, Huntley, D E, Metzler
openaire +2 more sources
Glutamic acid decarboxylase autoantibodies and neurological disorders
Neurological Sciences, 2002Glutamic acid decarboxylase (GAD) is the enzyme that catalyses the production of GABA, a major neurotransmitter of the central nervous system. Antibodies to GAD (GAD-Ab) were first recognised in a patient affected by stiff-person syndrome; subsequently they were reported in a large number of cases with type 1 diabetes.
Vianello M, Tavolato B, Giometto B
openaire +3 more sources
Encephalitis associated with glutamic acid decarboxylase autoantibodies
Neurology, 2001Antiglutamic acid decarboxylase (GAD-A) autoantibodies were originally reported in patients with stiff-man syndrome (SMS).1 Successive studies have shown that GAD-A was implicated in the pathogenesis of type 1 diabetes.2 High titers of GAD-A were recently reported in neurologic patients with disorders other than SMS, in particular ataxia3,4⇓ and ...
Marchiori GC +4 more
openaire +3 more sources
Cerebellar ataxia with glutamic acid decarboxylase autoantibodies
Neurology, 1999Degenerative cerebellar ataxia with autoantibodies against glutamic acid decarboxylase (GAD) is a rare disorder and may represent a subset of ataxias previously classified as idiopathic. The authors report a patient with progressive cerebellar ataxia, insulin-dependent diabetes mellitus, and GAD antibodies who responded to i.v. immunoglobulins.
M, Abele +5 more
openaire +2 more sources
Glutamate decarboxylase. Inhibition by monocarboxylic acids
Archives of Biochemistry and Biophysics, 1972Abstract Aliphatic monocarboxylic acids are demonstrated to be substrate competitive inhibitors of bacterial glutamate decarboxylase. A chain-length effect is observed in the inhibition by the monocarboxylic acids with n -valeric acid functioning as the most effective inhibitor.
openaire +2 more sources
Irreversible inhibition of glutamate decarboxylase by .alpha.-(fluoromethyl)glutamic acid
Biochemistry, 1981alpha-(Fluoromethyl)glutamic acid (FMG) was synthesized and shown to be an active site directed irreversible inhibitor of glutamate decarboxylase (EC 4.1.1.15) from Escherichia coli. The KI for the active enantiomer is 1.4 microM, and the kinh = 5.9 X 10(-3) s-1.
D, Kuo, R R, Rando
openaire +2 more sources
Effect of phosphonic analogues of glutamic acid on glutamate decarboxylase
Experientia, 1985Among the phosphonic analogues of glutamic acid, only 4-amino-4-phosphono butyric acid, the compound which shows the highest affinity for pyridoxal phosphate, inhibits competitively both Escherichia coli and rat brain glutamate decarboxylases. Phosphinothricin, 2-amino-4-(methylphosphino)butyric acid, is a strong inhibitor of the mammalian enzyme.
A M, Lacoste +3 more
openaire +2 more sources
Spectrophotometric assay of l-glutamic acid decarboxylase
Analytical Biochemistry, 1970Abstract A spectrophotometric method has been developed for the measurement of glutamic acid decarboxylase activity and applied to the kinetic study of the enzyme from Clostridium perfringens . The results are compared with those obtained by manometric method.
openaire +2 more sources

